Moderate

Cardiac disease in pregnancy — preconception & risk stratification

Maternal cardiac risk · Cardiac
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Pre-existing cardiac disease is a leading cause of maternal mortality. Preconception counselling and the modified WHO classification stratify risk, guide the safety of pregnancy, and plan a multidisciplinary approach to medication, monitoring and delivery.

Red flags

  • Severe pulmonary arterial hypertension (very high maternal mortality)
  • Severe symptomatic left-heart obstruction (e.g. mitral/aortic stenosis)
  • Marfan with aortic root >45 mm
  • Systemic ventricular EF <30% or NYHA III-IV
  • Prior peripartum cardiomyopathy with incomplete recovery

Assessment

Differential diagnosis

  • Congenital heart disease (repaired/unrepaired)
  • Valvular heart disease (especially mitral stenosis)
  • Cardiomyopathy (including peripartum)
  • Aortopathy (Marfan, bicuspid)
  • Pulmonary arterial hypertension
  • Ischaemic heart disease / arrhythmia

Investigations

  • Transthoracic echo for structure and function
  • ECG and ambulatory monitoring if arrhythmia
  • Aortic imaging (MRI) in aortopathy
  • Functional capacity assessment
  • NT-proBNP as a baseline
  • Review of current cardiac medications for teratogenicity

Management

  • Offer preconception counselling to all women with known cardiac disease
  • Apply the modified WHO (mWHO) classification to estimate maternal risk
  • Advise against pregnancy in mWHO class IV conditions (e.g. severe PAH, severe systemic ventricular dysfunction, Marfan with dilated aorta)
  • Review and switch teratogenic drugs (ACEi/ARB, warfarin, spironolactone) before conception
  • Optimise cardiac lesions before pregnancy where feasible (e.g. valve intervention)
  • Establish a pregnancy heart-team (cardiology, obstetrics, anaesthesia)
  • Plan antenatal monitoring intensity by risk class
  • Manage anticoagulation decisions in mechanical valves carefully across trimesters
  • Make a documented delivery plan including mode and location of delivery
  • Monitor for heart failure, arrhythmia and aortic events during pregnancy
  • Plan postpartum monitoring, including for peripartum cardiomyopathy
  • Advise on safe contraception

Drugs & doses

Labetalol 100-400 mg PO BD/TDS (pregnancy-safe antihypertensive)
Bisoprolol/metoprolol as pregnancy-compatible beta-blocker for arrhythmia/HF
Low-molecular-weight heparin for anticoagulation (mechanical valve regimens individualised)
Avoid ACEi, ARB, spironolactone and (in early pregnancy) warfarin
Hydralazine/nifedipine for blood pressure where needed

Disposition

Refer to a pregnancy heart-team / specialist obstetric cardiology service; preconception counselling and documented delivery planning.

Complications & pitfalls

  • Maternal heart failure
  • Arrhythmia
  • Aortic dissection
  • Thromboembolism (especially mechanical valves)
  • Fetal growth restriction and prematurity

Exam pearls

  • mWHO class IV conditions warrant advice against pregnancy and discussion of termination if it occurs
  • ACEi/ARB and spironolactone are contraindicated — switch before conception
  • Mechanical valve anticoagulation in pregnancy requires specialist individualised planning
  • Haemodynamic burden peaks in the third trimester and around delivery
  • Severe pulmonary arterial hypertension carries extremely high maternal mortality

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.